Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

1.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
1.2K
Structure and Function of Platelets01:18

Structure and Function of Platelets

988
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
988
Hematopoiesis01:21

Hematopoiesis

5.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.1K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

4.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integration of the naive pluripotency gene network with the response to GSK3 inhibition by Tcf7l1-driven enhancer decommissioning.

Stem cell reports·2026
Same author

Multiome-based identification of molecular markers for prospective identification of platelet-biased HSCs.

Stem cell reports·2026
Same author

Cytotoxic and Genotoxic Stress Transiently Increase the Contribution of Platelet-Biased Hematopoietic Stem Cells to Platelet Production.

Experimental hematology·2026
Same author

Age-dependent regulation of hematopoiesis by megakaryocytes.

Current opinion in hematology·2026
Same author

Morphometric analysis of the thymic epithelial cell network using integrated and orthogonal digital pathology approaches.

Communications biology·2026
Same author

Rheostats, not switches: Nuclear receptor dosage tunes somatic-to-iPSC reprogramming.

Stem cell reports·2026

Related Experiment Video

Updated: Jun 5, 2025

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
10:25

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

9.3K

Platelet Factor 4 (PF4) Regulates Hematopoietic Stem Cell Aging.

Sen Zhang, Charles E Ayemoba, Anna M Di Staulo

    Biorxiv : the Preprint Server for Biology
    |December 9, 2024
    PubMed
    Summary
    This summary is machine-generated.

    Aging bone marrow stem cells (HSCs) can be rejuvenated by Platelet Factor 4 (PF4). Restoring PF4 levels reverses age-related HSC dysfunction, offering new therapeutic avenues for hematopoietic diseases.

    More Related Videos

    Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells
    06:41

    Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells

    Published on: May 19, 2023

    1.7K
    Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors
    12:03

    Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors

    Published on: July 8, 2012

    18.6K

    Related Experiment Videos

    Last Updated: Jun 5, 2025

    Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
    10:25

    Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

    Published on: August 9, 2019

    9.3K
    Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells
    06:41

    Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells

    Published on: May 19, 2023

    1.7K
    Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors
    12:03

    Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors

    Published on: July 8, 2012

    18.6K

    Area of Science:

    • Hematology
    • Stem Cell Biology
    • Aging Research

    Background:

    • Hematopoietic stem cells (HSCs) and their bone marrow niches undergo age-related changes.
    • These changes impair immune function and increase susceptibility to blood cancers.
    • The megakaryocytic niche and Platelet Factor 4 (PF4) are implicated in HSC aging.

    Purpose of the Study:

    • To investigate the role of the megakaryocytic niche and PF4 in HSC aging.
    • To determine if PF4 can reverse age-related HSC dysfunction.
    • To identify the receptors mediating PF4's effects on HSCs.

    Main Methods:

    • Studied PF4-deficient mice exhibiting accelerated HSC aging phenotypes.
    • Administered recombinant PF4 to aged mice and evaluated HSC function.
    • Identified LDLR and CXCR3 as PF4 receptors on HSCs using knockout models.
    • Assessed human HSC responses to PF4 signaling.

    Main Results:

    • PF4 deficiency mimicked accelerated HSC aging, causing lymphopenia and myeloid bias.
    • Recombinant PF4 restored aged HSCs to a youthful state, improving polarity and reducing DNA damage.
    • PF4 enhanced HSCs' in vivo reconstitution capacity and balanced lineage output.
    • LDLR and CXCR3 were confirmed as critical receptors for PF4 signaling in HSCs.
    • Human HSCs responded positively to PF4, indicating conserved rejuvenation potential.

    Conclusions:

    • Age-related decline in the megakaryocytic niche and PF4 is a key driver of HSC aging.
    • PF4 supplementation rejuvenates aged HSCs by signaling through LDLR and CXCR3.
    • Targeting PF4 offers a promising strategy for treating age-related hematopoietic disorders.